These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15496154

  • 1. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis.
    Rangan GK, Pippin JW, Couser WG.
    Kidney Int; 2004 Nov; 66(5):1838-48. PubMed ID: 15496154
    [Abstract] [Full Text] [Related]

  • 2. C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria.
    Rangan GK, Pippin JW, Coombes JD, Couser WG.
    Kidney Int; 2005 Feb; 67(2):492-503. PubMed ID: 15673297
    [Abstract] [Full Text] [Related]

  • 3. C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys.
    Nangaku M, Pippin J, Couser WG.
    J Am Soc Nephrol; 2002 Apr; 13(4):928-936. PubMed ID: 11912252
    [Abstract] [Full Text] [Related]

  • 4. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome.
    Nangaku M, Pippin J, Couser WG.
    J Am Soc Nephrol; 1999 Nov; 10(11):2323-31. PubMed ID: 10541291
    [Abstract] [Full Text] [Related]

  • 5. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.
    Rangan GK, Coombes JD.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2175-82. PubMed ID: 17550925
    [Abstract] [Full Text] [Related]

  • 6. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
    Wang Y, Wang YP, Tay YC, Harris DC.
    Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
    [Abstract] [Full Text] [Related]

  • 7. C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria.
    Rangan GK.
    World J Nephrol; 2016 May 06; 5(3):288-99. PubMed ID: 27152265
    [Abstract] [Full Text] [Related]

  • 8. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
    Vielhauer V, Berning E, Eis V, Kretzler M, Segerer S, Strutz F, Horuk R, Gröne HJ, Schlöndorff D, Anders HJ.
    Kidney Int; 2004 Dec 06; 66(6):2264-78. PubMed ID: 15569315
    [Abstract] [Full Text] [Related]

  • 9. Extrahepatic C6 is as effective as hepatic C6 in the generation of renal C5b-9 complexes.
    Timmerman JJ, van Dixhoorn MG, Schraa EO, van Gijlswijk-Janssen DJ, Muizert Y, Van ES LA, Daha MR.
    Kidney Int; 1997 Jun 06; 51(6):1788-96. PubMed ID: 9186868
    [Abstract] [Full Text] [Related]

  • 10. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.
    Lee VW, Harris DC.
    Nephrology (Carlton); 2011 Jan 06; 16(1):30-8. PubMed ID: 21175974
    [Abstract] [Full Text] [Related]

  • 11. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis.
    Hughes J, Nangaku M, Alpers CE, Shankland SJ, Couser WG, Johnson RJ.
    Am J Physiol Renal Physiol; 2000 May 06; 278(5):F747-57. PubMed ID: 10807586
    [Abstract] [Full Text] [Related]

  • 12. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
    Spicer ST, Tran GT, Killingsworth MC, Carter N, Power DA, Paizis K, Boyd R, Hodgkinson SJ, Hall BM.
    J Immunol; 2007 Jul 01; 179(1):172-8. PubMed ID: 17579035
    [Abstract] [Full Text] [Related]

  • 13. Albuminuria is not an aggravating factor in experimental focal glomerulosclerosis and hyalinosis.
    Okuda S, Oochi N, Wakisaka M, Kanai H, Tamaki K, Nagase S, Onoyama K, Fujishima M.
    J Lab Clin Med; 1992 Mar 01; 119(3):245-53. PubMed ID: 1371800
    [Abstract] [Full Text] [Related]

  • 14. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia.
    Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ.
    J Am Soc Nephrol; 1998 Feb 01; 9(2):231-42. PubMed ID: 9527399
    [Abstract] [Full Text] [Related]

  • 15. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
    Yazdani S, Hijmans RS, Poosti F, Dam W, Navis G, van Goor H, van den Born J.
    Dis Model Mech; 2015 Aug 01; 8(8):919-30. PubMed ID: 26035383
    [Abstract] [Full Text] [Related]

  • 16. Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content.
    Bertani T, Zoja C, Abbate M, Rossini M, Remuzzi G.
    Lab Invest; 1989 Feb 01; 60(2):196-204. PubMed ID: 2915514
    [Abstract] [Full Text] [Related]

  • 17. A protective role for programmed death 1 in progression of murine adriamycin nephropathy.
    Qin XH, Lee VW, Wang YP, Zheng GP, Wang Y, Alexander SI, Harris DC.
    Kidney Int; 2006 Oct 01; 70(7):1244-50. PubMed ID: 16900095
    [Abstract] [Full Text] [Related]

  • 18. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice.
    Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT.
    J Immunol; 2006 Sep 15; 177(6):4094-102. PubMed ID: 16951374
    [Abstract] [Full Text] [Related]

  • 19. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.
    Baker PJ, Ochi RF, Schulze M, Johnson RJ, Campbell C, Couser WG.
    Am J Pathol; 1989 Jul 15; 135(1):185-94. PubMed ID: 2672823
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis.
    Shu Y, Hoshi S, Tomari S, Watanabe T, Nagata M.
    Pathol Int; 2002 Mar 15; 52(3):214-23. PubMed ID: 11972865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.